FDA’s draft guidance on AI/ML has startups on high alert
Author, Eric Elsen, Forte Group. On January 7, 2025, the US Food and Drug Administration (FDA) released draft guidance titled “Artificial Intelligence and Machine Learning in Software as a Medical Device”. The document outlines expectations for pre-market applications and lifecycle management of AI-enabled medical software. While the document may have flown under many readers’ radar,…
